CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells
暂无分享,去创建一个
C. Janeway | L. Wen | F. Wong | R. Flavell | I. Visintin | L. Wen
[1] C. Fathman,et al. Islet-Infiltrating Lymphocytes from Prediabetic NOD Mice Rapidly Transfer Diabetes to NOD-scid/scid mice , 1995, Diabetes.
[2] T. Utsugi,et al. Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences. , 1995, Journal of immunology.
[3] E. Leiter,et al. Genetic and pathogenic basis of autoimmune diabetes in NOD mice. , 1994, Current opinion in immunology.
[4] L. Hood,et al. Organization of the V gene segments in mouse T-cell antigen receptor alpha/delta locus. , 1994, Genomics.
[5] Y. Wu,et al. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells , 1994, The Journal of experimental medicine.
[6] R. Jaenisch,et al. β2-Microglobulin–Deficient NOD Mice Do Not Develop Insulitis or Diabetes , 1994, Diabetes.
[7] E. Leiter,et al. Major Histocompatibility Complex Class I-Deficient NOD-B2mnull Mice are Diabetes and Insulitis Resistant , 1994, Diabetes.
[8] T. Utsugi,et al. Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice. , 1994, Journal of immunology.
[9] C. Benoist,et al. Major histocompatibility complex class I molecules are required for the development of insulitis in non‐obese diabetic mice , 1993, European journal of immunology.
[10] K. Yamagata,et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. , 1993, The Journal of clinical investigation.
[11] D B Corry,et al. Constructing polycompetitor cDNAs for quantitative PCR. , 1993, Journal of immunological methods.
[12] E. Unanue,et al. Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice. , 1993, Journal of immunology.
[13] J. Gribben,et al. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Allison,et al. CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help , 1993, The Journal of experimental medicine.
[15] T. Ogihara,et al. MHC-linked diabetogenic gene of the NOD mouse: molecular mapping of the 3' boundary of the diabetogenic region. , 1993, Biochemical and biophysical research communications.
[16] P. Bedossa,et al. Evidence for a preferential Vβ usage by the T cells which adoptively transfer diabetes in NOD mice , 1993, European journal of immunology.
[17] J. Allison,et al. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. , 1993, Science.
[18] E. Leiter,et al. Adoptive Transfer of Diabetes Into Immunodeficient NOD-scid/scid Mice: Relative Contributions of CD4+ and CD8+ T-Cells From Diabetic Versus Prediabetic NOD.NON-Thy-1a Donors , 1993, Diabetes.
[19] P. Linsley,et al. The role of the CD28 receptor during T cell responses to antigen. , 1993, Annual review of immunology.
[20] P. Linsley,et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 , 1992, Cell.
[21] P. Linsley,et al. B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes. , 1992, Journal of immunology.
[22] O. Simell,et al. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.
[23] L. Hood,et al. Organization, structure, and function of 95 kb of DNA spanning the murine T-cell receptor CαCδ region , 1992 .
[24] C. Janeway,et al. Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[25] H. Gaskins,et al. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Gribben,et al. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7 , 1991, The Journal of experimental medicine.
[27] J. Gribben,et al. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[28] C. Janeway,et al. An explanation for the protective effect of the MHC class II I–E molecule in murine diabetes , 1991, Nature.
[29] Soumitra Ghosh,et al. Genetic analysis of autoimmune type 1 diabetes mellitus in mice , 1991, Nature.
[30] D. Kioussis,et al. Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression , 1991, European journal of immunology.
[31] C. Janeway,et al. Exclusive Expression of MHC Class II Proteins on CD45+ Cells in Pancreatic Islets of NOD Mice , 1991, Diabetes.
[32] E. Clark,et al. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells , 1991, The Journal of experimental medicine.
[33] P. Linsley,et al. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation , 1991, The Journal of experimental medicine.
[34] K. Haskins,et al. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. , 1990, Science.
[35] J. Danska,et al. The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine T cell specificity for myoglobin peptides , 1990, The Journal of experimental medicine.
[36] D. Kioussis,et al. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain , 1990, Nature.
[37] R. Schwartz,et al. A cell culture model for T lymphocyte clonal anergy. , 1990, Science.
[38] G. Eisenbarth,et al. Major histocompatibility complex-linked diabetogenic gene of the nonobese diabetic mouse. Analysis of genomic DNA amplified by the polymerase chain reaction. , 1990, The Journal of clinical investigation.
[39] C. Thompson,et al. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[40] B. Kwon,et al. The structure of the mouse lymphocyte pore-forming protein perforin. , 1989, Biochemical and biophysical research communications.
[41] C. Boitard,et al. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells , 1987, The Journal of experimental medicine.
[42] H. Pircher,et al. Molecular analysis of the antigen receptor of virus‐specific cytotoxic T cells and identification of a new Vα family , 1987 .
[43] K. Yamamura,et al. Prevention of autoimmune insulitis by expression of I–E molecules in NOD mice , 1987, Nature.
[44] D. R. Gamble,et al. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. , 1985, The New England journal of medicine.
[45] A. Michael,et al. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. , 1985, Laboratory investigation; a journal of technical methods and pathology.